Novartis has agreed to acquire US biopharma Chinook Therapeutics for $3.5 billion. Chinook has two late-stage drugs in development – Atrasentan and Zigakibart – to treat...
There are only a few chemical and pharmaceutical companies that look back at a history of 150 years. Certainly, many companies claim such a long legacy, but if you only...
The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...
Cleanroom residues can be generated by the process, raw materials, certainly by people but a significant contributor to the residues in a cleanroom are the disinfectants...
India-based start-up Ashaya focuses on increasing the value of waste and turns this waste into high-quality materials and products that are more recyclable.
Seeking to clear billions of dollars worth of litigation claiming that its iconic baby powder causes cancer, Johnson & Johnson has announced it is now prepared to offer a...
